Location History:
- Evansville, IN (US) (1979 - 1985)
- Newburgh, IN (US) (1990 - 1995)
Company Filing History:
5 out of 142 
3 out of 3,684 
2 out of 637 
Years Active: 1979-1995
Title: Innovations of Claude E Gallian: A Pioneer in Pharmaceutical Patents
Introduction
Claude E Gallian is an accomplished inventor based in Newburgh, Indiana. With a total of 10 patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in formulation and drug delivery systems. His work reflects a deep commitment to advancing medical science and improving patient outcomes.
Latest Patents
Gallian's recent innovations include the "Gepirone dosage form," which presents compositions with extended-release properties. This invention incorporates a gepirone salt within a cellulosic polymer matrix, designed to release 90 to 95% of the drug over a duration of 18 to 24 hours, enhancing therapeutic efficacy. Another notable patent is the "Direct compression cholestyramine tablet and solvent-free coating," which describes a tableting method using cholestyramine agglomerates. The invention features a unique tablet design characterized by irregularly-shaped fragments that possess specific moisture content, combined with a solvent-free coating made predominantly of stearic acid and polyethylene glycol.
Career Highlights
Throughout his career, Claude E Gallian has collaborated with renowned companies such as Mead Johnson & Company and Bristol-Myers Squibb Company. His expertise and innovative mindset have made lasting impacts in the pharmaceutical industry, positioning him as a key figure in drug formulation and delivery.
Collaborations
Gallian has worked alongside esteemed professionals in the field, including colleagues Stephen T David and Robert J Bequette. Their collaborative efforts have contributed to the successful development and patenting of groundbreaking pharmaceutical technologies.
Conclusion
Claude E Gallian stands as a prominent inventor whose work continues to influence the pharmaceutical landscape. His patents demonstrate a commitment to innovation and a focus on improving healthcare through advanced drug formulations. As he continues to develop new technologies, his contributions will be felt in both the scientific community and by patients who benefit from these advancements.